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1. Introduction
Optimal  diagnostic  quality  non-invasive  alternatives  for  visualization  of  the  coronary
arteries  has  been  a  major  goal  with  the  advent  of  newer  cardiovascular  imaging  mo‐
dalities  such  as  coronary  computed  tomography  angiography  (CCTA)  and  magnetic
resonance coronary angiography (MRCA).  The challenges in  imaging coronaries  are  ob‐
vious.  The  technology  must  be  capable  of  visualizing  arteries  as  small  as  1.5  mm  to
delineate  luminal  and wall  pathology which becomes challenging as  many of  the arter‐
ies  are  engulfed  in  tissue  of  similar  composition.  Coronary  arteries  exhibit  rapid  mo‐
tion which poses  major  issues  with blurring of  images  due to  substantial  limitations  of
temporal  resolution.  Invasive  coronary  angiography  current  enjoys  the  best  temporal
resolution  (less  than 20  msec  )  for  real  time visualization  of  coronaries  and its  branch‐
es  but  comes  with  its  obvious  limitations.  CCTA  has  rapidly  risen  to  this  challenge
and  is  already  widely  employed  using  64  slice  detector  technology  and  is  outstanding
for  exclusion  of  CAD  with  substantial  advances  in  radiation  reduction  and  speed  of
acquisition.  MRCA  has  made  significant  improvements  in  technology  which  has  made
coronary imaging less  challenging using navigator  gating,  whole heart  imaging and us‐
ing  3Tesla  magnets,  with  the  big  advantage  of  no  radiation  and capability  of  non-con‐
trast  coronary  imaging  and  most  of  all  the  promise  of  a  true  “  one  stop  “
comprehensive  assessment.  However,  it  is  still  suboptimal  compared  to  CCTA  as  dis‐
cussed  subsequently  in  detail.  This  chapters  aims  to  discuss  MRCA  and  CCTA  with
regards  to  coronary  imaging  and  compare  and  contrast  both  these  imaging  modalities
with  one  another  and  also  highlight  some emerging  comparisons  of  CCTA to  invasive
coronary luminal  assessment technologies.
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2. Magnetic Resonance Coronary Angiography (MRCA)
Introduction: MRCA has been performed for close to 20 years with numerous advances in
technical and imaging aspects during this period although slower than CCTA explaining its
slower adoption [1]. Initially 2 dimensional k space segmented imaging was done, but most
centers now use whole heart free breathing navigator coronary MRI or targeted 3D imaging
to enable better reconstruction capabilities. Published studies from experienced centers have
shown excellent accuracy and superiority to conventional coronary angiography (CA) using
2 and 3 dimensional k space gradient echo MRCA (Table 1)[2]..
Although whole heart MRCA was initially performed with 4 channel cardiac coils and a
parallel imaging factor of 2 [3, 4] it has been limited due longer acquisition times and image
deterioration from diaphragmatic drift. Thirty two channel cardiac coils and higher parallel
imaging factor of 4 [5] has potential for enhanced coronary imaging with whole heart
MRCA. 3T MRCA gives higher signal to noise ratio (approximately 30%) but has its own
limitations such as constructive/destructive interference in images causing dark and bright
areas due to inherent in-homogeneities which worsen with strong magnetic fields [6]. Also
specific absorption rates can increase upto 4 fold with 3T systems limiting use of certain
imaging sequences. There are multiple components of MRCA namely cardiac triggering to
suppress cardiac motion, respiratory motion suppression (navigator, breath hold) pre-pulses
to enhance contrast noise ratio and image acquisition to enhance coronary arterial image
quality. Overall image sequences for coronaries include black blood (fast spin echo and dual
inversion) bright blood (segmented k space gradient echo and SSFP) all of which can be
used either with 2D or 3D imaging.
Investigator Technique Respiratory
Compensation
Number of
Subjects
RCA LM LAD LCX
Manning, 1993 2D GRE BH 25 100% 96% 100% 76%
Pennell, 1993 2D GRE BH 26 95% 95% 91% 76%
Duerinckx, 1994 2D GRE BH 20 100% 95% 86% 77%
Sakuma, 1994 2D GRE cine BH 18 100% 100% 100% 67%
Masui, 1995 2D GRE BH 13 85% 92% 100% 92%
Davis, 1996 2D GRE BH 33* 100% 100% 100% 100%
Li, 1993 3D GRE Multiple Averages 14 100% 100% 86% 93%
Post, 1996 3D GRE Retro Nav G 20 100% 100% 100% 100%
Wielopoiski, 1998 3D Seg EPI BH 32 100% 100% 100% 100%
Botnar, 1999 3D GRE Pro Nav G/C 13 97% 100% 100% 97%
Weber, 2003 3D SSFP Pro Nav G/C 12 100% 100% 100% 100%
Abbreviations: BH, breath hold; GRE, gradient echo; LAD, left anterior descending coronary artery; LCX, left circumflex cor‐
onary artery; LM, left main coronary artery; PRO Nav GAC, prospective navigator gating with correction; RCA, right coro‐
nary artery; Retro Nav, retrospective navigator gating; Seg EPL, segmented EPI; SSFP, steady state free precession, 3D
Table 1. Successful visualization of native coronary arteries using 2 and 3 dimensional k space gradient echo MRCA
[2].Obtained with permission
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3. Challenges for MRCA
Achieving optimal spatial and temporal resolution, accurate motion compensation, wide
anatomical coverage, and high signal and contrast to noise ratios are inherent challenges in
MRCA. Improvement in one parameter occurs at the expense of another. Other factors that
limit its widespread application in the acute setting include longer exam time, limited clini‐
cal monitoring in the scanner, device implants and other metallic objects that may need
clearance prior to scanning.
Cardiac motion compensation deserves special mention. Since the heart moves due to both
inherent motion and due to diaphragmatic movement and as the magnitude of this motion
is greater than the diameter of the coronary vessels substantial blurring occurs if motion
suppression techniques are not utilized [7]. A regular cardiac rhythm and reliable ECG gat‐
ing is crucial for cardiac motion suppression techniques to work. Also time intervals of ac‐
quisition has to be determined in advance to plan the preparatory pulses which is a
limitation. Acquisition is usually in mid-diastole due to least coronary motion and lasts for
50-150 milliseconds per cardiac cycle [8, 9].
As breath holds may be long during coronary imaging and impossible for some patients free
breathing MRCA is an alternative and numerous correction techniques such as multiple
averaging, chest wall bellows and navigator techniques have been attempted of which the
latter is the most widely used [10].
MRCA Acquisition Methods:
1. Pulse sequences:
Pulse sequence design has evolved from black blood spin echo sequences to bright blood se‐
quences such as gradient echo and steady state free precession (SSFP) imaging. Currently
GRE is the chosen acquisition scheme in the majority of MRCA studies.
2. Acquisition strategies:
This includes k-space acquisition, contrast –enhanced (intrinsic and extrinsic) MRCA, 2D
and 3D acquisitions. Despite many advances, the speed of acquisition and signal to noise ra‐
tio (SNR) remain limited. New strategies such as real time, parallel, time resolved and whole
heart imaging have been developed.
1. CONVENTIONAL SPIN ECHO MRI: A spin echo signal results from a 900 RF pulse fol‐
lowed by a 1800 pulse which refocuses the dephased spins up to a decay curve deter‐
mined by the T2 relaxation time.
2. 2D SEGMENTED k SPACE GRADIENT ECHO MRI: The most widely available MRCA
sequence is a 2D segmented k-space gradient echo acquisition usually performed in a
single breath hold of fewer than 12 heartbeats. Thick slices and breath hold variability
can limit registration of images from slice to slice however this sequence is adequate for
applications such as evaluation for anomalous coronaries.
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3. 3D MRI: The use of navigator respiratory gating has given access to three-dimensional
(3D) coronary magnetic resonance imaging techniques, allowing a 3D dataset to be ob‐
tained in a single acquisition. It provides higher spatial resolution and is less operator
dependent. However, it relies on a reproducible respiratory pattern, which is not al‐
ways present. Furthermore, 3D techniques are hampered by the saturation of blood sig‐
nal, which decreases the signal to-noise ratio and the contrast of blood to myocardium.
4. CONTRAST ENHANCED CORONARY MRI: The use of interstitial paramagnetic con‐
trast agents allows an improvement of signal and contrast. The disadvantage is the rap‐
id leakage out of the intravascular space, amounting to 50% during the first pass.
Multiple injections are necessary to cover the whole coronary artery tree. With the in‐
troduction of intravascular paramagnetic contrast agents [11, 12], the signal from blood
no longer relies on inflow of blood but rather on the presence of the contrast agent itself.
The imaging time can be prolonged with potential increased signal and in contrast, al‐
lowing a larger volume coverage and higher resolution.
5. 3T MRI: Imaging at higher field strength can enhance signal-to-noise ratio (SNR) and
enable higher spatial resolution. However, image quality may be hampered by in‐
creased susceptibility artifacts and RF inhomogeneity which may be addressed by
shortening the TE and acquisition time. High-field imaging at 3 Tenhances spiral
MRCA. A number of research groups already have demonstrated the feasibility of car‐
diac imaging at 7 T and beyond and have shown improved contrast between blood and
epicardial fat, better coronary vessel sharpness, and increased blood signal intensity of
the coronaries are obtained at 7 T than at 3 T [13].
Clinical Applications:
1. Anomalous coronary arteries:
C-MRA  provides  a  3D  spatial  relationship  to  great  vessels,  allowing  evaluation  of  the
origin  and  course  of  anomalous  coronary  arteries.  Accurate  delineation  of  proximal
course  has  been  shown  with  a  sensitivity  of  88-100%  and  specificity  of  100%  [14-19]
MRI  can  often  provide  a  definitive  diagnosis  in  patients  in  whose  X  ray  angiography
is  inconclusive.  See Table  2
Investigator Number of patients Correctly Classified Anomalous Vessels
McConnell, 1995 15 14 (93%)
Post, 1995 19 19 (100%)
Vilegen, 1997 12 11 (92%)
Taylor, 2000 25 24 (96%)
Bunce, 2003 26 26 (100%)
Razmi, 2001 12 12 (100%)
Table 2. Anomalous coronary assessment by MRCA.[2] (reproduced with permission)
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2. Coronary Artery Disease:
Clinical studies have produced variable results. Kim et al [20] performed the first multicen‐
ter trial in 109 patients with suspected CAD. Overall sensitivity and specificity was 93 and
42%, respectively. 84% of coronary segments were of diagnostic quality. Table 1 shows the
comparative sensitivities of MRCA to CA. An example of MRCA coronary artery delinea‐
tion is shown in Figures 1A and 1B
Sakuma et al [21] evaluated over 130 patients with significant CAD and found an overall ac‐
curacy of 87%, per patient sensitivity of 82% and specificity of 90%
Figure 1. Sliding partial MIP images of 3 T whole heart coronary MRA acquired with a patient-specific narrow acquisi‐
tion window (50 ms) in the cardiac cycle Journal of Cardiovascular Magnetic Resonance Vol. 11 Issue Suppl 1
2009-01-2
4. Coronary Computed Tomoraphy Angiography (CCTA)
Introduction: CCTA has been rapidly adopted in a short time span by institutions across the
world as the most widely used anatomic noninvasive imaging modality for coronary artery
assessment. A major reason for this is the existing wide use of CT for non-cardiac applica‐
tions and most institutions have access to a CT scanner. Thus, investing in a state of the art
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CT scanner serves multiple purposes and makes financial sense with opportunity for cardiac
and non-cardiac use. Although initially limited to electron beam scanners in the 1980’s
where imaging of the heart arteries took several seconds and processing several hours, with
the advent of multi-detector coronary computed CT technology (MDCT or multi slice
(MSCT)) in the late 1990’s, rapid advancement in scanner technology has enabled rapid
whole heart acquisitions in a few seconds. With such scanners post processing capabilities
on a 3D dataset is usually achievable in about 15-20 minutes.
CCTA requires high temporal resolution to minimize motion artifacts caused by cardiac mo‐
tion and breathing. This requires a fast gantry rotation with multiple detectors. Because the
coronaries are seen best when there is least motion, the diastolic phase is most optimal for
imaging and thus the temporal resolution must be less than the length of the diastolic phase.
High spatial resolution is also necessary to allow imaging of the coronary arteries which are
small and tortuous. At present, 64-detector row CT systems are the most widely employed
platform for performing CCTA. The 64 detectors allow an x-,y- axis (in-plane) spatial resolu‐
tion of near 0.4mm and the z-axis spatial resolution or slice thickness is almost 0.6mm. Fast
contiguous coverage of the heart is required to allow imaging of the entire heart in one
breath hold. This requires the multi-slice helical CT technique, each slice of the heart is col‐
lected in one or more heartbeats. There is a 30%-50% overlap between each slice. The scan
must be triggered to the heartbeat to allow gating so that imaging in multiple slices occurs
across multiple heartbeats. Table 3 below, is a summary of the state of art 64 slice CT scan‐
ners with their various technical specifications [22].
Table 3. Reproduced under permission from [22]
Patient preparation:
On the day of the test, patients should take medications as scheduled especially betablock‐
ers. Metformin should be avoided because of the potential adverse effects when used con‐
comitantly with iodinated contrast agents. Phosphodiesterase inhibitors should be avoided
48 hours before a CCTA because nitrates are needed to dilate the coronary arteries. Premedi‐
cation with mucomyst and hydration are recommended if the creatinine is elevated. If a con‐
trast allergy is present, premedication with steroids and antihistamines is required. A right
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antecubital IV that is at least 18-gauge is preferred. If heart rate is not low enough with oral
beta-blockers, IV beta-blockers may be useful.
Data Acquisition:
Two  types  of  ECG  gating  are  possible,  prospective  and  retrospective.  Prospective  is
where the scanner emits  radiation only at  a  predefined point  after  the R wave.  Mid-di‐
astole  occurs  at  70-75%  of  the  R-R  interval  and  during  this  time  in  the  cardiac  cycle,
there  is  minimum  amount  of  motion  enabling  better  coronary  imaging.  The  CT  beam
is  off  during all  other  points  in  the  cycle.  This  requires  a  regular  heart  rate  and is  the
preferred  method  of  imaging  because  of  the  low  radiation  dose.  In  retrospective  trig‐
gering  a  continuous  heart  scan  is  utilized.  Imaging  is  performed  throughout  systole
and diastole.  Left  ventricular  function data  is  hence available.  This  method of  gating is
used if  the patient’s  heart  rate  is  irregular  or  not  low enough for  64 slice  CT scanners.
Figure 2  below shows the different  modes of  CCCT acquisition [22].
 
 
 
 
Figure 2. Reproduced under permission from [22]
Radiation Exposure: Reported CTA effective radiation dose is higher than many other car‐
diac diagnostic procedures as described by the International Commission on Radiological
Protection (ICRP) 60 [23]. The rapid expansion of CCTA magnifies the importance of dose
reduction within the population. The clinical acceptance of CCTA will partially depend on
the radiation exposure and its consequences, particularly if it is going to be used at an earlier
stage of CAD detection. Some commonly used dose reduction strategies include:
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1. Restricting scan field to anatomy of interest (~1 cm above left main to ~1 cm below
heart)
2. Reducing peak mAs based on body size (non-contrast scout films may be used to esti‐
mate image noise)
3. Using ECG dependant current modulation with lowest mAs during systole. Narrowing
the width of the peak mAs phase
4. Reducing kV to 100 if body Wt is <85 kg
5. Use prospective gating if available.
With regards to radiation exposure numerous algorithms and acquisition techniques have
been developed as discussed previously to reduce exposure specifically prospective trig‐
gered acquisition [24] and high pitch acquisition with dual source CCTA [25].
5. Limitations
There are several limitations with CCTA. Patients unable to cooperate with scanning in‐
structions should be considered for other imaging modalities. Uncontrollable arrhythmias
can result in significant motion artifacts and multiple uninterpretable coronary segments.
Contraindications to iodinated contrast use include pregnancy, prior severe/anaphylactic
contrast reaction and renal insufficiency (but end-stage renal disease is not a contraindica‐
tion) for contrast-induced nephropathy. Certain conditions should raise concerns for the use
of pre-scan beta-blocker (chronic obstructive pulmonary disease/asthma, decompensated
heart failure, and advanced atrioventricular block) and nitroglycerin (severe aortic stenosis,
hypertrophic cardiomyopathy, recent phosphodiesterase-5 inhibitor use). Metallic objects
such as pacemakers, intra-cardiac defibrillator leads, prosthetic valves cause beam-harden‐
ing and streaking artifact over adjacent coronary arteries. Dense concentric coronary calcifi‐
cation causes a blooming artifact, which often leads to overestimation of degree of stenosis.
Clinical Applications:
Most Important Appropriate indications for CCTA
Chest pain evaluation after an uninterpretable or equivocal stress test
Chest pain evaluation in patients with an intermediate probability, an uninterpretable EKG and unable to
exercise
Acute chest pain evaluation, an intermediate pretest probability, no EKG changes, and serial enzymes negative
Suspected coronary anomalies in symptomatic patients
Coronary evaluation in new onset heart failure
Table 4.
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1. Anomalous coronary arteries: CTA provides a 3D spatial relationship to great vessels,
allowing evaluation of the origin and course of anomalous coronary arteries in a non–
invasive manner. It is the “gold standard” test for evaluating anomalous coronary arter‐
ies and has the highest level of appropriateness use for this indication.
Figure 3. 40 year old male with syncope during exercise. CCTA shows anomalous left main coronary artery take off
from right coronary cusp between aorta and RVOT
2. Coronary artery disease
i. Detection of Coronary Stenosis: With ongoing technical development, the diag‐
nostic performance of CT with respect to detection and quantification of obstruc‐
tive CAD is steadily improving. The confidence and accuracy to assess stenosis is
better in larger branches and in the absence of extensive coronary calcification. For
the assessment of individual coronary segments, the sensitivity to detect significant
coronary artery stenosis ranges between 64-99%, the specificity between 84- 98%,
with pooled average sensitivity of 87% and specificity of 96%. The positive predic‐
tive value is approximately 80% whereas the negative predictive value has been
consistently high in all the studies with a pooled average of 98%. Calcified coro‐
nary disease causes blooming artifacts, which increases apparent stenosis severity
of a lesion. The ability to quantify coronary stenosis severity has been modest com‐
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pared to invasive angiography given the limited spatial resolution of CT and
blooming artifacts of calcified lesions. There are numerous single-center [26-34] and
three multicenter studies [35-37] using different scanner technologies (Table 4)
[35-37] in symptomatic patients with suspected CAD.
Table 5. Adapted with permission from Chang et al [38].
 
 
 
 
 
Figure 4. CCTA of a 60 year old smoker with atypical chest pain and sub-maximal negative stress echo. Thick maxi‐
mum intensity projection (MIP) images and multiplanar reconstruction images (MPR) are shown showing focal high
grade stenosis in proximal-mid RCA accompanied by scattered calcified plaques throughout RCA, Coronary angio‐
gram was performed confirming CCTA findings.
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ii. Stents: CCTA is not optimal for the evaluation of coronary stents because the spa‐
tial resolution is not quite good enough to visualize the intrastent lumen, thus
should not be routinely used for the evaluation of coronary stents. Small stents
tend to cause blooming and beam hardening issues leading to poor delineation of
lumen. Lack of contrast in lumen is a sign of in-stent restenosis. Currently, larger
stents >3.5-4.0 mm may be adequately assessed [39].
Figure 5. Shows multiplanar reformats of the left anterior descending coronary artery with clear visualization of pat‐
ent stents and normal right and left circumflex coronary arteries. Reproduced from Cademartiri et al [39].
iii. Bypass Graft Analysis: CCTA may be used to assess bypass graft patency as well
as to evaluate the patient undergoing repeat bypass surgery. In repeat bypass sur‐
gery CCTA is utilized to identify the location of a previously utilized graft. Clips
may often create challenges in assessing bypass grafts because of beam hardening
artifact and their potential to obscure the graft lumen or anastomosis point. Below
is an example of a 3d surface rendering of patient with prior coronary artery by‐
pass surgery (Figure 6) [40]. The saphenous vein graft (SVG) to the right coronary
artery is seen taking off from the aorta and inserting into the RCA. The origins of 2
other SVG are also noted adjacent to the SVG to RCA going to the left coronary sys‐
tem. The maximum intensity projection reveals a significant stenosis in the inser‐
tion site of the SVG to RCA [40].
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Figure 6.
3. Role of CCTA in Emergency Department:
A significant amount of money is wasted on inappropriate chest pain evaluations and ad‐
missions. Given CTA’s high NPV, the test would most benefit the intermediate-probability
patients in the ED. By using CTA, hospitalization could be avoided in patients presenting to
ED with chest pain. Logistic issues such as ED scanner availability and 24 hour expertise in
CTA interpretation limit use of CTA in most institutions. Triple rule out protocols have been
developed and studied to rule out coronary disease, pulmonary embolism and aortic dissec‐
tion [27, 41, 42]. These are however not used widely due to logistic issues and since often
one or more of these 3 etiologies can be ruled out clinically. A recent meta analysis by Sa‐
mad et al [43] synthesized data from 9 studies involving 1349 patients presenting to the
emergency room with suspected acute coronary syndrome (ACS). Endpoint was the diag‐
nostic performance of CTA for ACS. The bivariate summary estimate of sensitivity of CTA
for ACS diagnosis was 95% (95% CI 88-100) and specificity was 87% (95% CI 83-92), yielding
a negative likelihood ratio of 0.06 (95% CI 0-0.14) and positive likelihood ratio of 7.4 (95% CI
4.8-10). Based on this meta analysis of all the clinical studies, coronary CTA with its high
sensitivity and a low negative likelihood ratio of 0.06, is effective in ruling out the presence
of ACS in low to intermediate risk patients presenting to the ED with acute chest pain. More
recently the role of CCTA in ER has been studied in 2 important randomized trials the AC‐
RIN-PA [44] and the ROMICAT-2. Both studies showed that CCTA has an outstanding neg‐
ative predictive value with low subsequent event rates although conventional management
including stress testing also achieved comparable results. There was shorter length of stay
and quicker discharge directly from ED in CCTA arm although costs were the same between
CCTA and conventional testing in ROMICAT-2. Also radiation doses and downstream test‐
ing were higher in CCTA arm in ROMICAT-2 [45]. An important point with regards to use
of CCTA in ED is that although a zero calcium score makes obstructive CAD highly unlikely
as a cause of chest pain it is now clear that young patients (age < 50, smokers) may present
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with non-calcified obstructive disease and thus should not be triaged based on a negative
calcium score alone (see Figure 7 below)
 
 
 
 
Figure 7. 30 year old male with history of 15 pack history of smoking, cocaine abuse presents with intermittent sub‐
sternal pressure of 3 days duration. Coronary CT was done. Non-contrast scan showed zero calcium score but CCTA
showed high grade stenosis in the LAD and diagonal. The image on left is a view of the mid LAD showing mainly non-
calcified obstructive plaque. Coronary angiography confirms high grade LAD.
4. Role of CCTA in Assessing Etiology of Cardiomyopathy
It is  extremely important to define the etiology of cardiomyopathies to enable appropri‐
ate management and therapies.  CCTA can be of critical importance to rule out ischemic
cardiomyopathy  in  a  non-invasive  manner.  CCTA  has  immensely  robust  accuracy  at
evaluating  the  proximal  vascular  bed  with  accuracy  approaching  almost  97-100%.  This
attribute  becomes  most  relevant  in  the  context  of  ischemic  cardiomyopathy  which  per
the  standardized  definition  proposed  by  Felker  et  al  [46][Patients  with  75% stenosis  of
left main or proximal LAD, patients with 75% stenosis of two or more epicardial vessels]
yields  a  very  high  diagnostic  odds  ratio  for  ischemic  cardiomyopathy.  Several  studies
have evaluated the diagnostic accuracy of CCTA in comparison with invasive angiogra‐
phy.  We performed a meta analysis  of  all  6  studies  involving 452 patients  with cardio‐
myopathy  of  undetermined  cause  who  underwent  CTA.  All  patients  also  underwent
diagnostic  invasive  angiography.  The  pooled  summary  estimate  of  sensitivity  was  98%
and specificity 97% yielding a negative likelihood ratio of 0.06 for ischemic cardiomyop‐
athy. The receiver operator curve analysis showed a robust discriminate diagnostic accu‐
racy of ischemic etiology with an AUC of 0.99( Figure 8).  With a pooled sensitivity of
98%, an ischemic etiology of left ventricular systolic dysfunction can be accurately “ruled
out” with CTA (>16 slices).  A negative study hence essentially excludes the presence of
ischemic  cardiomyopathy.  A positive  CTA effectively  “rules  in”  the  probability  that  an
underlying  cardiomyopathy  could  be  related  to  significant  epicardial  coronary  stenosis.
Hence, CTA can be considered as an invaluable imaging modality for evaluating patients
with left ventricular dysfunction of a suspected ischemic etiology [47].
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Figure 8. Diagnostic accuracy of CCTA for ischemic cardiomyopathy. Adapted with permission from Bhatti et al [47].
6. Comparison of MSCT angiography and Invasive angiography
Since the first report of Moshage et al over 17 years ago [48], numerous studies and meta
analyses have been published confirming the superior diagnostic performance of MSCT in
comparison with invasive angiography as the reference standard.. The largest meta analysis
to date collated data from 89 studies with 7516 patients [49]. Bivariate analysis yielded a
mean sensitivity and specificity were 97.2% (95% CI, 96.2% to 98.0%) and 87.4% (CI, 84.5% to
89.8%) for CT. Negative likelihood ratio was 0.03 (0.02-0.04) whereas the positive likelihood
ratio was modest at 7.7(6.2-9.5) area under the curve was 0.98 (CI, 0.96 to 0.99) for CT. The
resulting sensitivity of 98.1% for scanners with more than 16 detector rows was significantly
higher (P < 0.050) than that for scanners with a maximum of 16 rows (95.6%). The high nega‐
tive predictive value of CTA best suites it as an effective rule-out test for significant CAD.
Despite the use of newer generation scanners (>64 slice), coronary calcification remains the
Achilles heel of CTA. A recent analysis from the CORE 64 study demonstrated that the ro‐
bust AUC of CTA (0.93) significantly decreased to (0.81) in patients with calcium score >600
[50]. Furthermore, the negative predictive value of CTA decreased from 0.93 in patients with
Calcium score <100 to 0.75 in patients with calcium score >100. High pretest probability of
CAD and high calcium score negatively impacts the diagnostic performance of CTA and
must be carefully considered in test selection.
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7. Prognostic value
Whereas the diagnostic accuracy of CCTA has been rigorously established, increasing num‐
ber of studies have also evaluated the prognostic value of CCTA. A recent meta analysis in‐
cluded eighteen studies involving 9,592 patients with a median follow-up of 20 months for
adverse cardiac events [51]. The authors computed a pooled annualized event MACE rate of
8.8% for obstructive (any vessel with >50% luminal stenosis) disease versus 0.17% per year
for normal CCTA (p < 0.05) and 3.2% versus 0.15% for death or MI (p < 0.05) Figure 9. Fur‐
thermore, the pooled negative likelihood ratio for MACE after normal CCTA findings was
0.008 (95% CI: 0.0004 to 0.17, p < 0.001). Patients with a normal CTA can hence be confident‐
ly reassured given a very low risk of death, MI or revascularization fairly comparable to an
otherwise healthy population(<1%). Furthermore, the low event rate for normal CTA
(0.16%) is comparable to other well established non invasive risk stratification modalities in‐
cluding stress echocardiography (0.45%) and myocardial perfusion stress imaging (0.54%).
CTA has hence emerged as a well established clinical tool that carries not only robust diag‐
nostic accuracy but also has powerful predictive accuracy as well [51].
Figure 9. Adapted with permission from Hulten et al [51]
8. Physiological significance of stenoses identified by CTA
That, coronary angiography is merely a “luminogram” and does not provide much insight
into the hemodynamic significance of a stenotic lesion, is a fact that has been rigorously es‐
tablished for the past two decades. This well-recognized limitation has been documented re‐
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peatedly by intravascular ultrasound imaging and stress testing. It has been known that
coronary angiography often leads to overestimation of the functional significance of epicar‐
dial coronary stenoses. In this regard, fractional flow reserve (FFR) has emerged as a power‐
ful catheter based tool that provides robust information about the functional severity of the
lesion. FFR calculated from coronary pressure measurement, is a reliable, invasive index to
indicate if a stenosis is ischemia-related and can be determined in the catheterization labora‐
tory in a simple and rapid way. By taking the ratio of the coronary pressure measured distal
to the stenosis to aortic pressure as the normal perfusion pressure (distal coronary pressure/
aortic pressure) and obtaining these measurements when the microvascular resistance was
minimal and assumed to be constant (that is, at maximal hyperemia), the percentage of nor‐
mal coronary flow, or a fraction of normal flow (i.e., FFR), can be calculated. FFR has a uni‐
form normal value of 1.0 for every patient and every coronary artery; it is not dependent on
changes in heart rate, blood pressure, or contractility; it accounts for collateral flow; and it
has a sharp threshold value to indicate inducible ischemia: FFR < 0.75 always indicates indu‐
cible ischemia; FFR > 0.80 excludes ischemia in 90% of the cases [15, 17-20, 23, 46, 52-54]. The
grey zone is very limited, which is important for clinical decision making in an individual
patient. Coronary pressure measurements can be easily performed by a pressure wire, with
almost identical mechanical properties as normal guide wires, and barely prolong the proce‐
dure, even when multiple vessels are interrogated. The ischemic threshold of FFR has been
replicated independently with different noninvasive functional tests in numerous studies
(including exercise electrocardiography, dobutamine stress echocardiography, and MPI) as
well as alongside one another in the same population. An FFR >0.75 identified coronary
stenoses in patients with inducible myocardial ischemia with high sensitivity (88%), specific‐
ity (100%), positive predictive value (100%), and overall accuracy (93%). FFR has a high re‐
producibility and low intra-individual variability. Several randomized clinical trials
including DEFER, FAME and now FAME II have established the prognostic utility of
FFR.Consequently, now, measurement of FFR during invasive coronary angiography is the
gold standard for identifying coronary artery lesions that cause ischemia and improves clin‐
ical decision-making for revascularization.
Similar limitations of stenoses especially in the intermediate range (50-70%) are widely seen
in CT angiograms. This poses both diagnostic and therapeutic challenges. Meijboom et al
[55] evaluated 89 lesions in 79 patients with stable angina. Lesion correlation with invasive
angiography was performed and FFR of stenoses was measured. The authors demonstrated
very poor correlation between CTA and invasive coronary angiography with hemodynami‐
cally significant stenosis (FFR<0.75); diagnostic accuracy 64% for FFR <0.8 and 49% for FFR<
0.75. CTA overestimated the functional significance of coronary stenoses (poor specificity/
high false positive rate) even after excluding segments with high calcification and coronary
motion. Hence patients with intermediate stenoses on CTA require further evaluation by ei‐
ther FFR evaluation of stress testing.
Recently, evaluation of FFR from CCTA data (FFRCT) has been proposed as a noninvasive
method for identifying ischemic lesions. This employs the concept of computational fluid
dynamics (CFD) Koo et al [56] correlated FFR from CT data with invasive FFR in 103 pa‐
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tients (159 vessels) in a prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-
Causing Stenoses Obtained via Noninvasive Fractional Flow Reserve) study. On a per-vessel
basis, the accuracy, sensitivity, specificity, positive predictive value, and negative predictive
value were 84.3%, 87.9%, 82.2%, 73.9%, 92.2%, respectively, for FFRCT and were 58.5%,
91.4%, 39.6%, 46.5%, 88.9%, respectively, for CCTA stenosis yielding an AUC of 0.9 for FFR
CT and 0.75 for CTA. There was fair correlation between invasive FFR and FFRCT (r = 0.717,
p < 0.001) although FFR Ct had slight underestimation (0.022 ± 0.116, p = 0.016). The results
of the larger 285 patient DEFACTO trial comparing CT FFR and invasive FFR are awaited
later this year and would further consolidate the role of non invasive FFR in the evaluation
of intermediate coronary lesions see on CTA.
9. Complimentary role of CTA in guiding complex PCI like Chronic total
occlusion (CTOs)
The unprecedented spatial resolution and 3D reconstruction of the epicardial coronary ves‐
sels has led to its role as an indispensable tool in guiding complex coronary interventions
including recanalizing chronic total occlusions (CTO); the most challenging subset of com‐
plex coronary lesions. The display of CTA images as a 3D roadmap, side-by-side with live
angiography images is instrumental in providing the interventional team access to the oc‐
cluded channel. Furthermore, synchronization of the CTA image orientation with the C-
arm, allows for selection of the ideal treatment projection angle without additional contrast
medium or radiation exposure. Several studies have validated the use of CTA in guiding
CTO intervention [57].
10. Diagnostic accuracy of CTA for in-stent restenosis
Despite the introduction of drug eluting stents, instent restenosis (ISR) from neointimal hy‐
perplasia remains a real issue. For patients with recurrent chest pain following stent implan‐
tation, invasive coronary angiography is often performed to evaluate the presence of ISR.
However, the need for a noninvasive alternative approach for ISR detection is more desira‐
ble. The experience with older generation CTA systems (4 and 16 slice) in evaluation of ISR
was very disappointing largely related to motion and blooming artifacts. The improved spa‐
tial and temporal resolution with 64,128 and 256 slice scanners seems to have ameliorated
those limitations. Carrabba et al [58] performed a meta analysis of nine studies involving 598
participants with 978 stents evaluated for ISR with CTA (64 slice) using invasive coronary
angiography as the reference standard. More than 60% of the studied stents were >3 mm in
diameter. Approximately 10% of the stents were unassessable. The pooled sensitivity and
specificity of CTA was 86% (95% CI 80-91%) and 93%( 95% CI 91-95%) respectively yielding
an AUC of 0.94 for per stent analysis. The calculated positive and negative predictive values
were 70.4% and 97.2%, respectively. CTA can hence 64-MDCT can hence reliably rule out
ISR and further evaluation by means of invasive coronary angiography can be avoided.
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Caution is still advised for smaller stents and the fact that almost 10% of the studies were
still uninterpretable despite the use of 64 detector scanners.
11. Comparison of coronary computed tomography angiography and
magnetic resonance coronary angiography
This section aims to compare the techniques of coronary computed tomography angiogra‐
phy (CCTA) with magnetic resonance coronary angiography (MRCA) from the standpoint
of coronary and cardiac imaging.
12. Comparison of technical aspects CCTA to MRCA
Currently the majority of the institutions utilize 64 slice technology (in-plane spatial resolu‐
tion of 0.4 x 0.4 mm with a slice thickness of 0.6 mm and a 360o gantry rotation in about 330
milliseconds). More recently dual source CCTA technology has pushed the envelope further
and has delivered a temporal resolution of 70-83 msec with an in plane resolution of 0.4 mm
[59]. Furthermore, 256 and 320 slice CT- scanners are available in limited institutions across
the world which can image the entire heart in 1 beat thus obviating many limitations with
current 64 slice scanners such as irregular heart rhythm, breath hold issues and opening op‐
tions for perfusion CCCTA imaging.
The tremendous advantages that CCTA holds over MRCA with such high spatial resolution
relates to: 1. ability to visualize small diameter vessels including distal coronary branches, 2.
increased ability to quantify calcium and reduce blooming artifacts, 3. better visualization of
stents, and 4. better plaque morphology assessment. The temporal resolution advances in
CCTA has enabled: 1. enhanced ability to freeze cardiac motion, 2. additional reconstruction
capabilities within cardiac cycle, and 3. reduced scan time.
The obvious disadvantages of CCTA compared to MRCA are: 1. radiation exposure which
depending on the scanner, mode of acquisition and protocol modifications can range from 1
milliseivert to > 15 milliseiverts[60, 61], 2. use of iodinated contrast which could pose issues
for patients with underlying renal dysfunction, and 3. need for slow heart rates which re‐
quire use of beta-blockers.
13. One stop shop imaging : MRCA versus CCTA
A very attractive advantage with MRCA is that it can combined with detailed cardiac MRI ex‐
am to provide a “one stop shop” assessment is easily achievable where coronary disease,
valves, stress/rest perfusion for ischemia and viability and overall cardiac and adjacent thora‐
cic and extra-thoracic anatomy can be all studied without concern for nephrotoxic contrast or
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repetitive exposure to radiation. Furthermore, imaging sequences or views can easily be re‐
peated. Thus, a hybrid anatomic and functional assessment is clinically feasible at present in
centers with experience with MRCA. With CCTA, valves and ventricular function assessment
comes at the cost of higher radiation exposure as retrospective triggered acquisition is needed.
CT perfusion imaging for ischemia and viability is still not well validated compared to cardiac
MRI but has been performed for both viability [62, 63] and perfusion [64, 65] and is being tested
against SPECT in ongoing clinical trials. Promising new studies with CCTA with lower radia‐
tion doses encompassing a complete anatomical-functional assessment compared to tradition‐
al SPECT imaging has been published recently [66] but this aspect of CCTA is not ready for
clinical use. Although MRCA does offer high temporal resolution, good spatial resolution,
high soft tissue contrast and the ability to generate any three dimensional image without need
for ionizing radiation it is much more challenging to perform as it requires selection of the cor‐
rect pulse sequences and each pulse sequence needs many parallel slices or slab volumes to
cover the entire heart. Free breathing MRCA acquisitions can take 5-15 minutes compared to a
few seconds with current 64-320 slice CCTA. Spatial resolution of CCTA is superior to MRCA
(0.4 to -0.6 mm with CCTA compared to 1.5 mm with MRCA). The disadvantage for MRCA
compared to CCTA in terms of speed of acquisition is difficult to overcome although breath
hold MRCA may offer some improvement in time required for acquisition compared to free
breathing techniques [67]. The temporal resolution of CCTA is limited by the gantry rotation
speed and hence cannot be altered. On the contrary free breathing MRCA temporal resolution
can be flexibly determined using imaging parameters. The acquisition window position and
the length within the RR interval can be individually set [68]. This is an important advantage
with MRCA.
14. Diagnostic accuracy of CCTA versus MRCA for CAD
The diagnostic accuracy of CCTA is well established with it outstanding negative predic‐
tive value ( 97.2%) and moderate-to good positive predictive value (87.4%) based on cu‐
mulative data from 89 studies of 7519 patients( 69). This compares much more favorably
to MRCA which has a sensitivity of 87.1% and specificity of 70.3 % based on 20 studies
of 989 patients [69].  Furthermore, in patients suspected of CAD or with acute disease at
presentation,  CCTA  has  an  outstanding  negative  likelihood  ratio  of  0.03(0.02-0.04)  and
0.06(0.02-0.19)  respectively  [69].  A  meta-analysis  of  CCTA versus  MRCA [49]  and a  re‐
cent study comparing state of art 64 slice CCTA to 32 channel 3T MRCA [70] both con‐
cluded  that  although  both  modalities  performed  well  for  CAD  detection  CCTA
outperformed MRCA. Furthermore CCTA was completed in 13.9+/= 1.1 sec compared to
17 +/- 4.7 minutes for MRCA [70]. The expert consensus document on “appropriate” use
of CT and MRI imaging published in 2006 gave an appropriate indication for CCTA to
rule out significant CAD in patients with chest pain and intermediate likelihood of CAD.
On the contrary the document gave a recommendation of “inappropriate” for MRCA for
the same indication [71].  This reflects the lack of adequate data demonstrating the feasi‐
bility and accuracy for MRCA on a practical level across many institutions.
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15. Assessment of coronary anomalies and aneurysms: CCTA versus
MRCA
One important indication where MRCA could be very helpful is imaging for anomalous cor‐
onaries in children and young adults where exposure to radiation from CCTA is undesirable
[72]. Coronary arteries in MRCA can be imaged without nephrotoxic contrast administra‐
tion. The high T2/T1 signal in steady state free precession imaging (SSFP) acts as a natural
contrast agent providing coronary lumen definition [73]. However, SSFP imaging has great‐
er susceptibility to artifacts and newer sequences such as fast low angle shots (FLASH) show
better imaging characteristics at 3.0T compared to SSFP [74] also showing a 50% reduction in
scan time [75]. CCTA offers outstanding spatial resolution and is the widely preferred tech‐
nique at least in adults to evaluate anomalous coronaries as long as there are no inherent
contraindications to its use. ACC/AHA appropriate use guidelines for CCTA /MRI [71] gives
CCTA and MRCA an “ appropriate” indication score with CCTA receiving a higher score of
9 compared to MRCA which also receives a high score of 8. MRCA may also be used for
serial follow-up of coronary aneurysms which can be a sequelae of Kawasaki disease partic‐
ularly in adolescents and young adults who otherwise may need repeated angiography.[76,
77] CCTA again is excellent to delineate these aneurysms but suffers from limitations of re‐
petitive radiation exposure.
16. Comparison of Technical Challenges in Imaging for CCTA and
MRCA
16.1. Motion artifact issues : CCTA versus MRCA
Motion artifacts pose a significant problem with both MRCA and CCTA. In MRCA this
can be intrinsic  related to cardiac contraction /relaxation or  extrinsic  attributable  to dia‐
phragm and chest wall  movement during respiration [35].  Furthermore,  MRCA requires
expertise  to  perform  and  interpret  and  is  currently  limited  largely  to  academic  centers
with a dedicated 1.5 or a 3T cardiac magnet at least in North America. In CCTA motion
artifacts are related to patient motion and respiratory based artifact (as CCTA imaging is
during breath hold). In contrast 64 slice CCTA is available in most large institutions and
practices  and  the  training  and  interpretation  process  is  much  more  feasible  for  physi‐
cians desiring to practice this technology.
16.2. Calcification issues: CCTA versus MRCA
Calcification of  coronary arteries  is  seen in  at  least  50-70% of  patients  with atheroscler‐
otic  plaques  [78].  Calcium  poses  a  significant  limitation  for  accuracy  of  CCTA  due  to
blooming/beam hardening artifacts  compromising lumen assessment  [79].  However  it  is
not  a  limitation  for  MRCA  for  assessing  the  lumen  of  the  coronary  arteries  as  MRI
does  not  have  issues  with  beam  hardening  or  blooming.  Thus  lumen  visualization  is
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not  compromised [80].  The flip side of  this  is  the added advantage of  detection of  cor‐
onary calcium during the non-contrast  portion of  CCTA which serves  both to  diagnose
atherosclerosis  [81]  and  in  its  absence  make  obstructive  CAD  highly  unlikely  both  in
asymptomatic  patients  and in  patient  with suspected cardiac  etiology of  chest  pain [82,
83].  Coronary  calcium  also  provides  powerful  prognostic  information  and  is  incremen‐
tal  in  risk  assessment  beyond  traditional  risk  scores  like  Framingham  risk  scores  [84].
Furthermore,  identifying  substantial  calcium  may  also  help  in  decision  making  for  the
physician as  the  CCTA portion of  the  test  could be  cancelled and more  definitive  test‐
ing towards  significance  of  underlying lesion could be  pursued wither  with  stress  test‐
ing  or  angiography.  MRCA lack  this  important  “  heads  up”  diagnostic  advantage  that
CCTA  possess  as  part  of  its  armamentarium  due  to  its  inability  to  image  calcium.
More  recently  some  investigators  have  tried  to  exploit  the  different  capabilities  of
CCTA and MRCA by combining both technologies  in patients  with significant  calcifica‐
tion.  In  a  small  study of  18  patients  who underwent  64  slice  CCTA,  3D free  breathing
MRCA and coronary angiography,  MRCA had better  diagnostic  image quality and per‐
formed  better  in  detection  of  obstructive  CAD  in  coronary  segments  with  focal  rather
than  diffuse  calcification  and  overall  performed  better  than  CCTA  in  detecting  signifi‐
cant  CAD in patients  with high calcium scores  [80].
17. Imaging bypass grafts and stents: CCTA versus MRCA
CCTA is an outstanding modality for imaging bypass grafts. In a study by Liu and collea‐
gues [85] 228 patients underwent 64 slice CCTA to evaluate diagnostic accuracy of CCTA for
bypass graft disease. The sensitivity, specificity, positive negative predictive value and over‐
all accuracy were reported at an impressive 93.3%, 98.1%, 93.3%, 98.1%, and 97.7 % respec‐
tively. Major disadvantages include higher contrast dose, increased radiation from longer
scanning to cover the anatomy of origin and course of grafts and artifacts related to clips
from surgery. The anastamotic sites in particular can sometimes be challenging to evaluate.
In comparison, in a study by Langerak et al,[86] MRCA showed a sensitivity and specificity
of 83 and 100% for graft occlusion,82%, and 88% for graft stenosis >/= 50% and 73% and 80%
for graft stenosis >/= 70%. MRCA also suffers from signal void artifacts from metallic im‐
plants, clips, etc. In addition it seems to perform inferior to CCTA in consistently identifying
severely diseased yet patent vessels [86] making its widespread applicability for bypass
graft evaluation less feasible. Furthermore even though CCTA has limitations with radiation
the population with CABG are older and hence the lifetime risk of cancer is less of a con‐
cern. Newer generation 64 slice CCTA has also shown promise in imaging stent lumen al‐
though stents less than 3 mm tend to cause unacceptable degree of lumen visualization and
blooming artifacts (highest with tantalum stents and lowest with titanium and nitinol based
alloys) and CCTA is not recommended below this size. A recent study on coronary stent pa‐
tency with CCTA showed a promising 89% sensitivity and 95% specificity [87]. MRCA data
with stents is limited but the stainless steel composition of stents make imaging challenging
as in-stent integrity and persistent assessment can be compromised. The attractive force and
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local heart generated with stent imaging at 1.5 T and 3T is not a major issue the local sus‐
ceptibility artifacts can be a big problem [88, 89]. This is less of problem with tantalum com‐
pared to stainless steel stents. In the USA both Cypher and Taxus Liberte stents are
approved for imaging with MRI immediately after implantation.
18. Contrast issues: CCTA versus MRCA
CCTA has to utilize iodinated contrast agents between 80-120 ml for opacification of cor‐
onary vessels. This is an obvious limitation for those with underlying chronic kidney dis‐
ease particularly Stage 3 and above as it  is  potentially nephrotoxic.  MRCA on the other
hand utilizes the natural signal differences seen in SSFP imaging to visualize coronaries
and does not require gadolinium contrast although it can be utilized. Currently used ga‐
dolinium compounds remain intravascular only for  a  short  period of  time thus limiting
the benefit of contrast enhancement for MRCA for a short period of time. However some
advances  in  MRI  contrast  agents  have  been  made  with  newer  agents  with  more  pro‐
longed intravascular time now being available. These agents increase contrast to noise ra‐
tio  with  MRCA  and  hold  promise  to  improve  diagnostic  accuracy  although  no  large
scale studies have been performed as yet. It is important o note that gadolinium chelates
can cause nephrogenic systemic fibrosis and are usually contraindicated in patients with
glomerular filtration rates of < 30 ml/min.
19. Plaque imaging: CCTA versus MRCA
Plaque imaging is an exciting area of intense research and potential application of CCTA
given its capacity to image the vessel wall and provide information beyond luminal narrow‐
ing. It can detect and characterize atherosclerotic plaques as calcified, non-calcified and
mixed composition (Figure 10).[90] It is now known that regardless of degree of luminal
stenosis even non-obstructive plaques as detected by CCTA carries adverse prognosis [91].
However, inter-observer variability of measurement of plaque dimensions is substantial and
routine plaque measurements is not feasible at this time. However CCTA shows promise in
identifying certain high risk characteristics such as bulky plaques, spotty calcification and
positive remodeling all of which have been shown to be related to acute coronary syn‐
dromes [92]. With MRI, although once felt to be not possible, several investigators have im‐
aged the coronary vessel wall and plaque successfully including subclinical wall thickening
[93, 94], although from point of practical applicability this has yet to find a place in the clini‐
cal arena. Because of the lack of radiation exposure in MRCA it is ideally suited for follow-
up imaging for assessing plaque progression [95] or to follow-up intermediate range
stenosis where anatomy can be combined with a functional assessment of significance of le‐
sion with stress –rest perfusion sequences [96].
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Figure 10.
20. Patient acceptance of CCTA versus MRCA
CCTA enjoys a much shorter time to completion of study compared to MRCA (20 versus 60
minutes respectively) which is a major attraction from the patient perspective [97]. For a mo‐
dality to be overall successful in clinical practice it should not only be accurate, demonstrate
clinical benefit and cost effective but also preferred by patients [98]. Studies have shown that
patients prefer CCTA to MRCA [99]. This is mainly driven by longer imaging times, confine‐
ment in closed space and noise associated with MR imaging.
21. Training issues CCTA versus MRCA
Guidelines exist both from American College of Radiology [100] and the American College
of Cardiology [101] for specific training requirements for gaining expertise in CCTA. Un‐
fortunately no such guidelines exist for MRCA and given the complexity involved in image
acquisition the degree of expertise needed to independently perform and interpret MRCA is
likely to substantially greater with regards to training requirements. CCTA program clearly
is easier to establish and execute than a MRCA program.
Table 5 summarizes various advantages and disadvantages from the authors perspective of
CCTA and MRCA.
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Table 6.
22. Future perspectives
Noninvasive coronary angiography involving CCTA and MRCA has revolutionized delin‐
eation of coronary anatomy in a safe and fast way. CCTA has advanced much more in this
aspect with fast imaging with single breath holds and 1 beat acquisition lasting a few sec‐
onds. The radiation and iodine based contrast are the major disadvantages although cur‐
rently radiation doses below 1 millisievert are achievable with CCTA. MRCA with whole
heart 3D imaging and 32 channel coils and 3T magnets have improved coronary imaging
significantly but still lags behind and is not available widely. We foresee that CCTA will be‐
come mainstream for coronary imaging in low to intermediate risk populations with chest
pains syndromes in the near future with exciting prospects of comprehensive cardiac imag‐
ing of perfusion and viability and plaque imaging.
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